Salhany, K E <br/><br/>
Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders.  [electronic resource] 

 -  Blood  May 1997 
 - 3490-1 p.  digital 
<br/><br/> Publication Type: Comment; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chromosomes, Human, Pair 7<br/>Cyclophosphamide<br/>Doxorubicin<br/>Humans<br/>Kidney Transplantation<br/>Liver Neoplasms--drug therapy<br/>Lymphoma, T-Cell--drug therapy<br/>Postoperative Complications<br/>Prednisolone<br/>Receptors, Antigen, T-Cell, alpha-beta--genetics<br/>Receptors, Antigen, T-Cell, gamma-delta--genetics<br/>Splenic Neoplasms--drug therapy<br/>T-Lymphocyte Subsets--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Trisomy<br/>Vincristine